Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Why do diabetic patients with multiple risk factors develop plaque progression rapidly despite interventional procedure and statin treatment.

Seo JG, Han SH, Kim SH, Ahn TH, Koh KK.

Int J Cardiol. 2013 Oct 3;168(3):2962-4. doi: 10.1016/j.ijcard.2013.03.113. Epub 2013 Apr 18. No abstract available.

PMID:
23602869
2.

Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era.

Tousek P, Pavei A, Oreglia J, Martin G, Sharif F, Fajadet J, Farah B.

EuroIntervention. 2009 Mar;4(5):588-92.

PMID:
19378678
3.

Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme.

Onuma Y, Kukreja N, Ramcharitar S, Hochadel M, Gitt A, Serruys P.

EuroIntervention. 2009 Mar;4(5):578-87.

PMID:
19378677
4.

Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.

Kataoka Y, Shao M, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ.

Eur J Prev Cardiol. 2013 Apr;20(2):209-17. doi: 10.1177/2047487312437931. Epub 2012 Jan 31.

PMID:
22345692
5.

Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.

Laynez A, Sardi G, Hauville C, Barbash IM, Pakala R, Torguson R, Xue Z, Satler LF, Pichard AD, Waksman R.

Catheter Cardiovasc Interv. 2013 Apr;81(5):759-65. doi: 10.1002/ccd.24438. Epub 2012 Apr 23.

PMID:
22488756
6.

Do systemic risk factors impact invasive findings from virtual histology? Insights from the international virtual histology registry.

Philipp S, Böse D, Wijns W, Marso SP, Schwartz RS, König A, Lerman A, Garcia-Garcia HM, Serruys PW, Erbel R.

Eur Heart J. 2010 Jan;31(2):196-202. doi: 10.1093/eurheartj/ehp428. Epub 2009 Oct 23.

PMID:
19854730
7.

Percutaneous drug-eluting stent implantation in diabetic patients: short and long term outcomes from an observational study.

Longo G, Gonella A, D'Ascenzo F, Quadri G, Bollati M, Biondi-Zoccai G, Moretti C, Omedè P, Sciuto F, Gaita F, Sheiban I.

Minerva Cardioangiol. 2011 Feb;59(1):1-7.

PMID:
21285926
8.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
9.

Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).

Kereiakes DJ, Cutlip DE, Applegate RJ, Wang J, Yaqub M, Sood P, Su X, Su G, Farhat N, Rizvi A, Simonton CA, Sudhir K, Stone GW.

J Am Coll Cardiol. 2010 Dec 14;56(25):2084-9. doi: 10.1016/j.jacc.2010.10.006.

10.

Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology.

Capodanno D, Tamburino C, Sangiorgi GM, Romagnoli E, Colombo A, Burzotta F, Gasparini GL, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio AS, Loi B, Lyoi E, Benassi A, Patti A, Gaspardone A, De Servi S; I-BIGIS Study Group.

Circ Cardiovasc Interv. 2011 Feb 1;4(1):72-9. doi: 10.1161/CIRCINTERVENTIONS.110.959460. Epub 2011 Jan 4.

11.

Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I.

Coron Artery Dis. 2014 Jun;25(4):343-8. doi: 10.1097/MCA.0000000000000084.

PMID:
24448173
12.

A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.

Wenaweser P, Eshtehardi P, Abrecht L, Zwahlen M, Schmidlin K, Windecker S, Meier B, Haeberli A, Hess OM.

Thromb Haemost. 2010 Sep;104(3):554-62. doi: 10.1160/TH09-11-0765. Epub 2010 Jul 20.

PMID:
20664903
13.

Impacts of conventional coronary risk factors, diabetes and hypertension, on coronary atherosclerosis during statin therapy: subanalysis of the TRUTH study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Coron Artery Dis. 2012 Jun;23(4):239-44. doi: 10.1097/MCA.0b013e328351f919.

PMID:
22441135
14.

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD).

Eur Heart J. 2007 Jan;28(1):88-136. No abstract available.

PMID:
17220161
15.
16.

Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials.

Vardi M, Burke DA, Bangalore S, Pencina MJ, Mauri L, Kandzari DE, Leon MB, Cutlip DE.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1031-8. doi: 10.1002/ccd.25045. Epub 2013 Jul 4.

PMID:
23737390
17.

No easy fixes.

Taqueti VR.

N Engl J Med. 2013 Oct 10;369(15):1392-3. doi: 10.1056/NEJMp1303484. No abstract available.

18.

Polymer-free stents in diabetic patients-not so sweet after all!

Bansilal S, Mehran R.

Catheter Cardiovasc Interv. 2014 Feb 15;83(3):425-6. doi: 10.1002/ccd.25352. No abstract available.

PMID:
24497456
19.

Give me FREEDOM or...

King SB 3rd.

JACC Cardiovasc Interv. 2012 Nov;5(11):1190-1. doi: 10.1016/j.jcin.2012.10.002. No abstract available.

20.

Predictors for very late stent thrombosis after drug-eluting stent implantation in diabetic patients.

Voudris V, Kariofillis P, Thomopoulou S, Patsilinakos S, Manginas A, Spargias C, Pavlides G, Cokkinos DV.

EuroIntervention. 2009 Jan;4(4):485-91.

PMID:
19284071

Supplemental Content

Support Center